ISPE conference content highlights supply chain

ISPE is offering content from its conference held earlier this month. Some speakers were recorded and the content is accessible as downloadable webinars. Content was also delivered virtually via live webcasts and live online speaker presentations.

One session, on global supply chain integrity and anti-counterfeiting, brought together industry leaders and FDA regulators to address concerns about maintaining a safe, efficacious drug supply, according to an announcement.

Amgen Vice President Martin VanTrieste, representing the newly formed Rx360 supply chain organization, was a presenter. He discussed geopolitical environmental scanning, a way "to detect, in advance, potential weaknesses in or disruptions to the supply chain that could lead to contamination, adulteration, or counterfeiting," according to a Pharmaceutical Technology magazine blog on the conference.

- see the ISPE selection of conference content
- review our earlier coverage of Rx360
- visit the PharmTech blog

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.